ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-11S4402
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antibody Market Research Report 2021
BUY CHAPTERS

Global Antibody Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-11S4402
Report
May 2025
Pages:172
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Merck
Novartis
AbbVie
Amgen Inc
Pfizer Inc
Bayer
Lilly
Bristol–Myers Squibb
GlaxoSmithKline PLC
Biogen
Astrazeneca plc
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Johnson and Johnson

Antibody Market Size

In 2024, the global market size of Antibody was estimated to be worth US$ 10070 million and is forecast to reach approximately US$ 14390 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.

Antibody Market

Antibody Market

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody.
The Antibody market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Antibody Market Report

Report Metric Details
Report Name Antibody Market
Forecasted market size in 2031 approximately US$ 14390 million
CAGR 5.3%
Forecasted years 2025 - 2031
Segment by Type
  • IgM
  • IgG
  • IgA
  • Other
Segment by Application
  • Therapeutic
  • Research
  • Diagnostic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Johnson and Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Antibody Market size in 2031?

Ans: The Antibody Market size in 2031 will be approximately US$ 14390 million.

What is the market share of major companies in Antibody Market?

Ans: Global top five players hold a share about 35%.

What is the Antibody Market share by type?

Ans: In terms of product, IgG is the largest segment, with a share about 80%.

Who are the main players in the Antibody Market report?

Ans: The main players in the Antibody Market are Roche, Johnson and Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics

What are the Application segmentation covered in the Antibody Market report?

Ans: The Applications covered in the Antibody Market report are Therapeutic, Research, Diagnostic

What are the Type segmentation covered in the Antibody Market report?

Ans: The Types covered in the Antibody Market report are IgM, IgG, IgA, Other

Recommended Reports

Antibody Markets

Immunology Drugs

Diagnostics & Research

1 Study Coverage
1.1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antibody Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody Market Size Estimates and Forecasts
2.1.1 Global Antibody Revenue 2020-2031
2.1.2 Global Antibody Sales 2020-2031
2.2 Antibody Market Size by Region: 2024 Versus 2031
2.3 Antibody Sales by Region (2020-2031)
2.3.1 Global Antibody Sales by Region: 2020-2025
2.3.2 Global Antibody Sales Forecast by Region (2026-2031)
2.3.3 Global Antibody Sales Market Share by Region (2020-2031)
2.4 Antibody Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Antibody Revenue by Region: 2020-2025
2.4.2 Global Antibody Revenue Forecast by Region (2026-2031)
2.4.3 Global Antibody Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Antibody Sales by Type (2020-2031)
3.1.1.1 Global Antibody Sales Volume by Type (2020-2031)
3.1.1.2 Global Antibody Sales Market Share by Type (2020-2031)
3.1.2 Global Antibody Revenue by Type (2020-2031)
3.1.2.1 Global Antibody Revenue by Type (2020-2031)
3.1.2.2 Global Antibody Revenue Market Share by Type (2020-2031)
3.1.3 Antibody Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Antibody Sales by Application (2020-2031)
3.2.1.1 Global Antibody Sales Volume by Application (2020-2031)
3.2.1.2 Global Antibody Sales Market Share by Application (2020-2031)
3.2.2 Global Antibody Revenue by Application (2020-2031)
3.2.2.1 Global Antibody Revenue by Application (2020-2031)
3.2.2.2 Global Antibody Revenue Market Share by Application (2020-2031)
3.2.3 Antibody Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 IgM of Antibody Revenue Market Share by Application
3.3.2 IgG of Antibody Revenue Market Share by Application
3.3.3 IgA of Antibody Revenue Market Share by Application
3.3.4 Other of Antibody Revenue Market Share by Application
4 Global Antibody by Manufacturers
4.1 Global Top Antibody Manufacturers by Sales (2020-2025)
4.1.1 Global Antibody Sales by Manufacturer (2020-2025)
4.1.2 Global Antibody Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Antibody Manufacturers by Revenue (2020-2025)
4.2.1 Global Antibody Revenue by Manufacturer (2020-2025)
4.2.2 Global Antibody Revenue Share by Manufacturer (2020-2025)
4.3 Global Antibody Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Antibody Manufacturers Covered: Ranking by Revenue
4.4.2 Global Antibody Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Antibody Manufacturing Base Distribution, Product Type
4.5.1 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Antibody Market
4.5.3 Manufacturers Antibody Product Type and Application
4.5.4 IgM Market Sales of Antibody by Manufacturer
4.5.5 IgG Market Sales of Antibody by Manufacturer
4.5.6 IgA Market Sales of Antibody by Manufacturer
4.5.7 Other Market Sales of Antibody by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Company Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Antibody Products Offered
5.1.4 Roche Antibody Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Roche Antibody Sales by Product in 2024
5.1.6 Roche Antibody Sales by Application in 2024
5.1.7 Roche Antibody Sales by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Johnson and Johnson
5.2.1 Johnson and Johnson Company Information
5.2.2 Johnson and Johnson Description, Business Overview
5.2.3 Johnson and Johnson Antibody Products Offered
5.2.4 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Johnson and Johnson Antibody Sales by Product in 2024
5.2.6 Johnson and Johnson Antibody Sales by Application in 2024
5.2.7 Johnson and Johnson Antibody Sales by Geographic Area in 2024
5.2.8 Johnson and Johnson Recent Developments
5.3 Merck
5.3.1 Merck Company Information
5.3.2 Merck Description, Business Overview
5.3.3 Merck Antibody Products Offered
5.3.4 Merck Antibody Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Merck Antibody Sales by Product in 2024
5.3.6 Merck Antibody Sales by Application in 2024
5.3.7 Merck Antibody Sales by Geographic Area in 2024
5.3.8 Merck Recent Developments
5.4 Novartis
5.4.1 Novartis Company Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Antibody Products Offered
5.4.4 Novartis Antibody Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Antibody Sales by Product in 2024
5.4.6 Novartis Antibody Sales by Application in 2024
5.4.7 Novartis Antibody Sales by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 AbbVie
5.5.1 AbbVie Company Information
5.5.2 AbbVie Description, Business Overview
5.5.3 AbbVie Antibody Products Offered
5.5.4 AbbVie Antibody Sales, Revenue and Gross Margin (2020-2025)
5.5.5 AbbVie Antibody Sales by Product in 2024
5.5.6 AbbVie Antibody Sales by Application in 2024
5.5.7 AbbVie Antibody Sales by Geographic Area in 2024
5.5.8 AbbVie Recent Developments
5.6 Amgen
5.6.1 Amgen Company Information
5.6.2 Amgen Description, Business Overview
5.6.3 Amgen Antibody Products Offered
5.6.4 Amgen Antibody Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Amgen Antibody Sales by Product in 2024
5.6.6 Amgen Antibody Sales by Application in 2024
5.6.7 Amgen Antibody Sales by Geographic Area in 2024
5.6.8 Amgen Recent Developments
5.7 Pfizer
5.7.1 Pfizer Company Information
5.7.2 Pfizer Description, Business Overview
5.7.3 Pfizer Antibody Products Offered
5.7.4 Pfizer Antibody Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Pfizer Antibody Sales by Product in 2024
5.7.6 Pfizer Antibody Sales by Application in 2024
5.7.7 Pfizer Antibody Sales by Geographic Area in 2024
5.7.8 Pfizer Recent Developments
5.8 Bayer
5.8.1 Bayer Company Information
5.8.2 Bayer Description, Business Overview
5.8.3 Bayer Antibody Products Offered
5.8.4 Bayer Antibody Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Bayer Antibody Sales by Product in 2024
5.8.6 Bayer Antibody Sales by Application in 2024
5.8.7 Bayer Antibody Sales by Geographic Area in 2024
5.8.8 Bayer Recent Developments
5.9 Lilly
5.9.1 Lilly Company Information
5.9.2 Lilly Description, Business Overview
5.9.3 Lilly Antibody Products Offered
5.9.4 Lilly Antibody Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Lilly Antibody Sales by Product in 2024
5.9.6 Lilly Antibody Sales by Application in 2024
5.9.7 Lilly Antibody Sales by Geographic Area in 2024
5.9.8 Lilly Recent Developments
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Company Information
5.10.2 Bristol-Myers Squibb Description, Business Overview
5.10.3 Bristol-Myers Squibb Antibody Products Offered
5.10.4 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Bristol-Myers Squibb Antibody Sales by Product in 2024
5.10.6 Bristol-Myers Squibb Antibody Sales by Application in 2024
5.10.7 Bristol-Myers Squibb Antibody Sales by Geographic Area in 2024
5.10.8 Bristol-Myers Squibb Recent Developments
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Company Information
5.11.2 GlaxoSmithKline Description, Business Overview
5.11.3 GlaxoSmithKline Antibody Products Offered
5.11.4 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2020-2025)
5.11.5 GlaxoSmithKline Antibody Sales by Product in 2024
5.11.6 GlaxoSmithKline Antibody Sales by Application in 2024
5.11.7 GlaxoSmithKline Antibody Sales by Geographic Area in 2024
5.11.8 GlaxoSmithKline Recent Developments
5.12 Biogen
5.12.1 Biogen Company Information
5.12.2 Biogen Description, Business Overview
5.12.3 Biogen Antibody Products Offered
5.12.4 Biogen Antibody Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Biogen Antibody Sales by Product in 2024
5.12.6 Biogen Antibody Sales by Application in 2024
5.12.7 Biogen Antibody Sales by Geographic Area in 2024
5.12.8 Biogen Recent Developments
5.13 AstraZeneca
5.13.1 AstraZeneca Company Information
5.13.2 AstraZeneca Description, Business Overview
5.13.3 AstraZeneca Antibody Products Offered
5.13.4 AstraZeneca Antibody Sales, Revenue and Gross Margin (2020-2025)
5.13.5 AstraZeneca Antibody Sales by Product in 2024
5.13.6 AstraZeneca Antibody Sales by Application in 2024
5.13.7 AstraZeneca Antibody Sales by Geographic Area in 2024
5.13.8 AstraZeneca Recent Developments
5.14 Sanofi
5.14.1 Sanofi Company Information
5.14.2 Sanofi Description, Business Overview
5.14.3 Sanofi Antibody Products Offered
5.14.4 Sanofi Antibody Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Sanofi Antibody Sales by Product in 2024
5.14.6 Sanofi Antibody Sales by Application in 2024
5.14.7 Sanofi Antibody Sales by Geographic Area in 2024
5.14.8 Sanofi Recent Developments
5.15 Alexion Pharmaceuticals
5.15.1 Alexion Pharmaceuticals Company Information
5.15.2 Alexion Pharmaceuticals Description, Business Overview
5.15.3 Alexion Pharmaceuticals Antibody Products Offered
5.15.4 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Alexion Pharmaceuticals Antibody Sales by Product in 2024
5.15.6 Alexion Pharmaceuticals Antibody Sales by Application in 2024
5.15.7 Alexion Pharmaceuticals Antibody Sales by Geographic Area in 2024
5.15.8 Alexion Pharmaceuticals Recent Developments
5.16 Seattle Genetics
5.16.1 Seattle Genetics Company Information
5.16.2 Seattle Genetics Description, Business Overview
5.16.3 Seattle Genetics Antibody Products Offered
5.16.4 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Seattle Genetics Antibody Sales by Product in 2024
5.16.6 Seattle Genetics Antibody Sales by Application in 2024
5.16.7 Seattle Genetics Antibody Sales by Geographic Area in 2024
5.16.8 Seattle Genetics Recent Developments
6 North America
6.1 North America Antibody Market Size YoY Growth 2020-2031
6.2 North America Antibody Market Facts & Figures by Country
6.2.1 North America Antibody Sales by Country (2020-2031)
6.2.2 North America Antibody Revenue by Country (2020-2031)
6.3 North America Antibody Sales by Type (2020-2025)
6.4 North America Antibody Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Antibody Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Antibody Market Facts & Figures by Region
7.2.1 Asia-Pacific Antibody Sales by Region (2020-2031)
7.2.2 Asia-Pacific Antibody Revenue by Region (2020-2031)
7.3 Asia-Pacific Antibody Sales by Type (2020-2025)
7.4 Asia-Pacific Antibody Sales by Application (2020-2025)
8 Europe
8.1 Europe Antibody Market Size YoY Growth 2020-2031
8.2 Europe Antibody Market Facts & Figures by Country
8.2.1 Europe Antibody Sales by Country (2020-2031)
8.2.2 Europe Antibody Revenue by Country (2020-2031)
8.3 Europe Antibody Sales by Type (2020-2025)
8.4 Europe Antibody Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Antibody Market Size YoY Growth 2020-2031
9.2 Latin America Antibody Market Facts & Figures by Country
9.2.1 Latin America Antibody Sales by Country (2020-2031)
9.2.2 Latin America Antibody Revenue by Country (2020-2031)
9.3 Latin America Antibody Sales by Type (2020-2025)
9.4 Latin America Antibody Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Antibody Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Antibody Market Facts & Figures by Country
10.2.1 Middle East and Africa Antibody Sales by Country (2020-2031)
10.2.2 Middle East and Africa Antibody Revenue by Country (2020-2031)
10.3 Middle East and Africa Antibody Sales by Type (2020-2025)
10.4 Middle East and Africa Antibody Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Antibody Supply Chain Analysis
11.2 Antibody Key Raw Materials and Upstream Suppliers
11.3 Antibody Clients Analysis
11.4 Antibody Sales Channel and Sales Model Analysis
11.4.1 Antibody Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Antibody Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Antibody Distributors
12 Antibody Market Dynamics
12.1 Antibody Industry Trends
12.2 Antibody Market Drivers
12.3 Antibody Market Challenges
12.4 Antibody Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Roche
Merck
Novartis
AbbVie
Amgen Inc
Pfizer Inc
Bayer
Lilly
Bristol–Myers Squibb
GlaxoSmithKline PLC
Biogen
Astrazeneca plc
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Johnson and Johnson
List of Tables
 Table 1. Global Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Antibody Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Antibody Sales by Region (2020-2025) & (KG)
 Table 5. Global Antibody Sales Forecast by Region (2026-2031) & (KG)
 Table 6. Global Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Antibody Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Antibody Sales Volume by Type (2020-2025) & (KG)
 Table 9. Global Antibody Sales Volume by Type (2026-2031) & (KG)
 Table 10. Global Antibody Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Antibody Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Antibody Sales Volume by Application (2020-2025) & (KG)
 Table 13. Global Antibody Sales Volume by Application (2026-2031) & (KG)
 Table 14. Global Antibody Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Antibody Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Antibody Sales by Manufacturer (2020-2025) & (KG)
 Table 17. Global Antibody Sales Share by Manufacturer (2020-2025)
 Table 18. Antibody Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Antibody Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Antibody Price (2020-2025) & (USD/KG)
 Table 21. Ranking of Global Top Antibody Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody as of 2024)
 Table 24. Antibody Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Antibody Market
 Table 26. Manufacturers Antibody Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Roche Company Information
 Table 29. Roche Description and Business Overview
 Table 30. Roche Antibody Product
 Table 31. Roche Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 32. Roche Sales Proportion of Antibody by Product in 2024
 Table 33. Roche Sales Proportion of Antibody by Application in 2024
 Table 34. Roche Sales Proportion of Antibody by Geographic Area in 2024
 Table 35. Roche Recent Developments
 Table 36. Johnson and Johnson Company Information
 Table 37. Johnson and Johnson Description and Business Overview
 Table 38. Johnson and Johnson Antibody Product
 Table 39. Johnson and Johnson Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 40. Johnson and Johnson Sales Proportion of Antibody by Product in 2024
 Table 41. Johnson and Johnson Sales Proportion of Antibody by Application in 2024
 Table 42. Johnson and Johnson Sales Proportion of Antibody by Geographic Area in 2024
 Table 43. Johnson and Johnson Recent Developments
 Table 44. Merck Company Information
 Table 45. Merck Description and Business Overview
 Table 46. Merck Antibody Product
 Table 47. Merck Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 48. Merck Sales Proportion of Antibody by Product in 2024
 Table 49. Merck Sales Proportion of Antibody by Application in 2024
 Table 50. Merck Sales Proportion of Antibody by Geographic Area in 2024
 Table 51. Merck Recent Developments
 Table 52. Novartis Company Information
 Table 53. Novartis Description and Business Overview
 Table 54. Novartis Antibody Product
 Table 55. Novartis Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 56. Novartis Sales Proportion of Antibody by Product in 2024
 Table 57. Novartis Sales Proportion of Antibody by Application in 2024
 Table 58. Novartis Sales Proportion of Antibody by Geographic Area in 2024
 Table 59. Novartis Recent Developments
 Table 60. AbbVie Company Information
 Table 61. AbbVie Description and Business Overview
 Table 62. AbbVie Antibody Product
 Table 63. AbbVie Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 64. AbbVie Sales Proportion of Antibody by Product in 2024
 Table 65. AbbVie Sales Proportion of Antibody by Application in 2024
 Table 66. AbbVie Sales Proportion of Antibody by Geographic Area in 2024
 Table 67. AbbVie Recent Developments
 Table 68. Amgen Company Information
 Table 69. Amgen Description and Business Overview
 Table 70. Amgen Antibody Product
 Table 71. Amgen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 72. Amgen Sales Proportion of Antibody by Product in 2024
 Table 73. Amgen Sales Proportion of Antibody by Application in 2024
 Table 74. Amgen Sales Proportion of Antibody by Geographic Area in 2024
 Table 75. Amgen Recent Developments
 Table 76. Pfizer Company Information
 Table 77. Pfizer Description and Business Overview
 Table 78. Pfizer Antibody Product
 Table 79. Pfizer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 80. Pfizer Sales Proportion of Antibody by Product in 2024
 Table 81. Pfizer Sales Proportion of Antibody by Application in 2024
 Table 82. Pfizer Sales Proportion of Antibody by Geographic Area in 2024
 Table 83. Pfizer Recent Developments
 Table 84. Bayer Company Information
 Table 85. Bayer Description and Business Overview
 Table 86. Bayer Antibody Product
 Table 87. Bayer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 88. Bayer Sales Proportion of Antibody by Product in 2024
 Table 89. Bayer Sales Proportion of Antibody by Application in 2024
 Table 90. Bayer Sales Proportion of Antibody by Geographic Area in 2024
 Table 91. Bayer Recent Developments
 Table 92. Lilly Company Information
 Table 93. Lilly Description and Business Overview
 Table 94. Lilly Antibody Product
 Table 95. Lilly Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 96. Lilly Sales Proportion of Antibody by Product in 2024
 Table 97. Lilly Sales Proportion of Antibody by Application in 2024
 Table 98. Lilly Sales Proportion of Antibody by Geographic Area in 2024
 Table 99. Lilly Recent Developments
 Table 100. Bristol-Myers Squibb Company Information
 Table 101. Bristol-Myers Squibb Description and Business Overview
 Table 102. Bristol-Myers Squibb Antibody Product
 Table 103. Bristol-Myers Squibb Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 104. Bristol-Myers Squibb Sales Proportion of Antibody by Product in 2024
 Table 105. Bristol-Myers Squibb Sales Proportion of Antibody by Application in 2024
 Table 106. Bristol-Myers Squibb Sales Proportion of Antibody by Geographic Area in 2024
 Table 107. Bristol-Myers Squibb Recent Developments
 Table 108. GlaxoSmithKline Company Information
 Table 109. GlaxoSmithKline Description and Business Overview
 Table 110. GlaxoSmithKline Antibody Product
 Table 111. GlaxoSmithKline Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 112. GlaxoSmithKline Sales Proportion of Antibody by Product in 2024
 Table 113. GlaxoSmithKline Sales Proportion of Antibody by Application in 2024
 Table 114. GlaxoSmithKline Sales Proportion of Antibody by Geographic Area in 2024
 Table 115. GlaxoSmithKline Recent Developments
 Table 116. Biogen Company Information
 Table 117. Biogen Description and Business Overview
 Table 118. Biogen Antibody Product
 Table 119. Biogen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 120. Biogen Sales Proportion of Antibody by Product in 2024
 Table 121. Biogen Sales Proportion of Antibody by Application in 2024
 Table 122. Biogen Sales Proportion of Antibody by Geographic Area in 2024
 Table 123. Biogen Recent Developments
 Table 124. AstraZeneca Company Information
 Table 125. AstraZeneca Description and Business Overview
 Table 126. AstraZeneca Antibody Product
 Table 127. AstraZeneca Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 128. AstraZeneca Sales Proportion of Antibody by Product in 2024
 Table 129. AstraZeneca Sales Proportion of Antibody by Application in 2024
 Table 130. AstraZeneca Sales Proportion of Antibody by Geographic Area in 2024
 Table 131. AstraZeneca Recent Developments
 Table 132. Sanofi Company Information
 Table 133. Sanofi Description and Business Overview
 Table 134. Sanofi Antibody Product
 Table 135. Sanofi Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 136. Sanofi Sales Proportion of Antibody by Product in 2024
 Table 137. Sanofi Sales Proportion of Antibody by Application in 2024
 Table 138. Sanofi Sales Proportion of Antibody by Geographic Area in 2024
 Table 139. Sanofi Recent Developments
 Table 140. Alexion Pharmaceuticals Company Information
 Table 141. Alexion Pharmaceuticals Description and Business Overview
 Table 142. Alexion Pharmaceuticals Antibody Product
 Table 143. Alexion Pharmaceuticals Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 144. Alexion Pharmaceuticals Sales Proportion of Antibody by Product in 2024
 Table 145. Alexion Pharmaceuticals Sales Proportion of Antibody by Application in 2024
 Table 146. Alexion Pharmaceuticals Sales Proportion of Antibody by Geographic Area in 2024
 Table 147. Alexion Pharmaceuticals Recent Developments
 Table 148. Seattle Genetics Company Information
 Table 149. Seattle Genetics Description and Business Overview
 Table 150. Seattle Genetics Antibody Product
 Table 151. Seattle Genetics Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 152. Seattle Genetics Sales Proportion of Antibody by Product in 2024
 Table 153. Seattle Genetics Sales Proportion of Antibody by Application in 2024
 Table 154. Seattle Genetics Sales Proportion of Antibody by Geographic Area in 2024
 Table 155. Seattle Genetics Recent Developments
 Table 156. North America Antibody Sales by Country (2020-2025) & (KG)
 Table 157. North America Antibody Sales by Country (2026-2031) & (KG)
 Table 158. North America Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 159. North America Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 160. North America Antibody Sales by Type (2020-2025) & (KG)
 Table 161. North America Antibody Sales by Application (2020-2025) & (KG)
 Table 162. Asia-Pacific Antibody Sales by Region (2020-2025) & (KG)
 Table 163. Asia-Pacific Antibody Sales by Region (2026-2031) & (KG)
 Table 164. Asia-Pacific Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 165. Asia-Pacific Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 166. Asia-Pacific Antibody Sales by Type (2020-2025) & (KG)
 Table 167. Asia-Pacific Antibody Sales by Application (2020-2025) & (KG)
 Table 168. Europe Antibody Sales by Country (2020-2025) & (KG)
 Table 169. Europe Antibody Sales by Country (2026-2031) & (KG)
 Table 170. Europe Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 171. Europe Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 172. Europe Antibody Sales by Type (2020-2025) & (KG)
 Table 173. Europe Antibody Sales by Application (2020-2025) & (KG)
 Table 174. Latin America Antibody Sales by Country (2020-2025) & (KG)
 Table 175. Latin America Antibody Sales by Country (2026-2031) & (KG)
 Table 176. Latin America Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 177. Latin America Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 178. Latin America Antibody Sales by Type (2020-2025) & (KG)
 Table 179. Latin America Antibody Sales by Application (2020-2025) & (KG)
 Table 180. Middle East and Africa Antibody Sales by Country (2020-2025) & (KG)
 Table 181. Middle East and Africa Antibody Sales by Country (2026-2031) & (KG)
 Table 182. Middle East and Africa Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 183. Middle East and Africa Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 184. Middle East and Africa Antibody Sales by Type (2020-2025) & (KG)
 Table 185. Middle East and Africa Antibody Sales by Application (2020-2025) & (KG)
 Table 186. Antibody Key Raw Materials, Industry Status and Trend
 Table 187. Antibody Key Raw Materials and Upstream Suppliers
 Table 188. Antibody Clients Status and Trend
 Table 189. Antibody Typical Clients
 Table 190. Antibody Distributors
 Table 191. Antibody Market Trends
 Table 192. Antibody Market Drivers
 Table 193. Antibody Market Challenges
 Table 194. Antibody Market Restraints
 Table 195. Research Programs/Design for This Report
 Table 196. Key Data Information from Secondary Sources
 Table 197. Key Data Information from Primary Sources
 Table 198. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Antibody Product Picture
 Figure 2. Global Antibody Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Antibody Sales Market Share by Type in 2024 & 2031
 Figure 4. IgM Product Picture
 Figure 5. IgG Product Picture
 Figure 6. IgA Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Antibody Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Antibody Sales Market Share by Application in 2024 & 2031
 Figure 10. Therapeutic
 Figure 11. Research
 Figure 12. Diagnostic
 Figure 13. Antibody Report Years Considered
 Figure 14. Global Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Antibody Market Size 2020-2031 (US$ Million)
 Figure 16. Global Antibody Sales 2020-2031 (KG)
 Figure 17. Global Antibody Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Antibody Revenue Market Share by Region (2020-2031)
 Figure 19. Global Antibody Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Antibody Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Antibody Average Selling Price (ASP) by Type (2020-2025) & (USD/KG)
 Figure 22. Global Antibody Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Antibody Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Antibody Average Selling Price (ASP) by Application (2020-2025) & (USD/KG)
 Figure 25. IgM of Antibody Revenue Market Share by Application, 2024 VS 2031
 Figure 26. IgG of Antibody Revenue Market Share by Application, 2024 VS 2031
 Figure 27. IgA of Antibody Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Other of Antibody Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Global Antibody Sales Share by Manufacturer in 2024
 Figure 30. Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. IgM Market Sales Proportion by Manufacturer in 2024
 Figure 32. IgG Market Sales Proportion by Manufacturer in 2024
 Figure 33. IgA Market Sales Proportion by Manufacturer in 2024
 Figure 34. Other Market Sales Proportion by Manufacturer in 2024
 Figure 35. North America Antibody Revenue 2020-2031 (US$ Million)
 Figure 36. North America Antibody Sales Market Share by Type (2020-2025)
 Figure 37. North America Antibody Sales Market Share by Application (2020-2025)
 Figure 38. Asia-Pacific Antibody Revenue 2020-2031 (US$ Million)
 Figure 39. Asia-Pacific Antibody Sales Market Share by Region (2020-2031)
 Figure 40. Asia-Pacific Antibody Revenue Market Share by Region (2020-2031)
 Figure 41. Asia-Pacific Antibody Sales Market Share by Type (2020-2025)
 Figure 42. Asia-Pacific Antibody Sales Market Share by Application (2020-2025)
 Figure 43. Europe Antibody Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Europe Antibody Sales Market Share by Country (2020-2031)
 Figure 45. Europe Antibody Revenue Market Share by Country (2020-2031)
 Figure 46. Europe Antibody Sales Market Share by Type (2020-2025)
 Figure 47. Europe Antibody Sales Market Share by Application (2020-2025)
 Figure 48. Latin America Antibody Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Latin America Antibody Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Antibody Revenue Market Share by Country (2020-2025)
 Figure 51. Latin America Antibody Sales Market Share by Type (2020-2025)
 Figure 52. Latin America Antibody Sales Market Share by Application (2020-2025)
 Figure 53. Middle East and Africa Antibody Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 54. Middle East and Africa Antibody Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Antibody Revenue Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Antibody Sales Market Share by Type (2020-2025)
 Figure 57. Middle East and Africa Antibody Sales Market Share by Application (2020-2025)
 Figure 58. Antibody Supply Chain (Upstream and Downstream Market)
 Figure 59. Global Production Market Share of Antibody Raw Materials by Region in 2024
 Figure 60. Antibody Distribution Channels
 Figure 61. Global Antibody Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 62. Global Antibody Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Antibody Production Services Market Research Report 2024
Global Anti HA Antibody Market Research Report 2024
Global Antibody Drugs Market Insights Forecast to 2030
Monoclonal Mouse Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biologics Monoclonal Antibodies Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Research Grade Antibodies Market Research Report 2024
Global Myoglobin Monoclonal Antibody Market Research Report 2024
Global Monoclonal Antibody Sequencing Market Research Report 2025
Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030
Global Monoclonal Antibodies Product Market Research Report 2024
Global Next Generation Monoclonal Antibodies Market Research Report 2024
Biosimilars of Rituximab Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hybridoma Technology Market Research Report 2024
Global Recombinant Rabbit Monoclonal Antibodies Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions